Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-24T19:47:07.437Z Has data issue: false hasContentIssue false
  • English
  • Français

Alendronate overdose/intoxication: Suicidal attempt in a case report

Published online by Cambridge University Press:  13 August 2021

T. Gutiérrez Higueras ,
F. Calera Cortés ,
S. Vicent Forés  and
S. Sainz De La Cuesta Alonso
T. Gutiérrez Higueras*
Affiliation:
Clinical Unit Of Mental Health., Reina Sofia University Hospital., Córdoba., Spain
F. Calera Cortés
Affiliation:
Clinical Unit Of Mental Health., Reina Sofia University Hospital., Córdoba., Spain
S. Vicent Forés
Affiliation:
Clinical Unit Of Mental Health., Reina Sofia University Hospital., Córdoba., Spain
S. Sainz De La Cuesta Alonso
Affiliation:
Clinical Unit Of Mental Health., Reina Sofia University Hospital., Córdoba., Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Alendronate is a nitrogen-containing biphosphonate that inhibits osteoclastic bone resorption. Lethal dose (LD50) was aproximately 626mg/kg in male rats, and 552mg/kg in female. Signs and Symptoms of overdose clammy skin, CNS depression, dysphagia, hiccups, miosis, respiratory depression, seizures and wheezing. Supportive therapy and monitor of urine flow, calcium and phsophorous level is essential for the management of voluntary overdose.

Objectives

To present the case of a 76-year-old woman who made a suicide attempt by ingestion of 8 tablets of 70 mg of alendronate.To describe the treatment of alendronate poisoning and the follow-up parameters for the control of complications.

Methods

Clinical case presentation through retrospective review of clinical notes and non-systematic literature review.

Results

A 76-year-old woman was taken to the emergency department after voluntarily ingesting 8 alendronate tablets (70 mg per tablet) 1 hour ago reporting “suicidal thoughts”. After clinical evaluation, gastric lavage, administration of activated charcoal, and IV ranitidine were used. After 24-hour observation and after psychiatric evaluation, the patient was discharged.

Conclusions

Hypocalcaemia, hypophosphataemia and upper gastrointestinal adverse reactions, such as upset stomach, heartburn, oesophagitis, gastritis, or ulcer, may result from oral overdose. In case of overdose with alendronate, milk or antacids should be given to bind alendronate. Giving milk or antacids, to bind the bisphosphonate and minimize absorption, has been suggested for oral overdose. Due to the risk of esophageal irritation, vomiting should not be induced and the patient should remain fully upright. For decontamination is recomended activated charcoal and gastric lavage.

Disclosure

No significant relationships.

Keywords

alendronateSuicideIntoxicationTreatment
Type
Abstract
Information
European Psychiatry , Volume 64 , Special Issue S1: Abstracts of the 29th European Congress of Psychiatry , April 2021 , pp. S828
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.